Upcoming Events


09
Dec 20

ESCP General Assembly 2020

Wednesday, 09. Dec 2020, 20:00 – Wednesday, 09. Dec 2020, 22:00, Webinar, Netherlands


26
Apr 21

ESCP International Workshop 2021 in Zurich

Monday, 26. Apr 2021, 8:30 – Tuesday, 27. Apr 2021, 18:00, Zurich, Switzerland

Malnutrition and malabsorption affect many patients inside and outside hosptials. Our workshop will provide basic and practical knowledge on causes and impact of malnutrition and malabsorption as well as practical tools and exercises ensuring adequate drug therapy in those patients.

Malnutrition is common and can be caused by malabsorption, decreased nutrient intake, or hypermetabolism due to illness or injury. It is associated with a longer hospital stay, increased morbidity and mortality, increased incidence of infection, poor wound healing, and decreased immune competence. Many gastrointestinal disorders like Crohn’s disease or interventions such as bariatric surgery lead to an altered absorption of food as well as drugs. Affected patients may need specific drug therapy and nutritional supplements such as antidiarrheal medicine, proton pump blockers or vitamins. The risk of nutritional deficiencies depends on the type of surgical procedures, the location and the extent of the resection. Short and long-term complications are common and close monitoring is required. Enteral or parenteral feeding must be installed with caution in malnourished patients in order to avoid a refeeding syndrome. Drug therapy in patients in patients with parenteral nutrition is challenging due to possible incompatibilities. Medication application via an enteral tube requires a careful selection and preparation of dosage forms and appropriate administration methods. Pharmacists can play an important role in taking care of those patients together with nurses, physicians and dieticians.

ABSTRACT SUBMISSION OPENS 1 NOVEMBER 2020

READ MORE


20
Oct 21

ESCP Symposium 2021 in Lisbon

Wednesday, 20. Oct 2021, 9:00 – Friday, 22. Oct 2021, 18:00, Lisbon, Portugal

The 49th ESCP Symposium will provide attendees with the opportunity to be involved in the discussion around mental health issues in the context of clinical pharmacy. Features of interest include updates on dementia, depression, anxiety and psychosis treatment.

During the symposium, every day there will be a lecture focusing on pharmacotherapy updates, highlighting evidence-based therapy and controversies in the treatment of dementia, depression and anxiety. Other topics focused in plenary lectures will include: number needed to treat and number needed to harm in mental health; treatment of dementia-related pain; deprescribing of benzodiazepines; treatment of mental health using digital technology to reach the youth; comparing the benefits of pharmacotherapy and psychotherapy, to name a few. There will also be masterclasses focusing on general research and educational themes, namely “Bring your paper to get it published” and “Teaching by the bedside” or “Multivariate statistical analsyis”. We welcome workshop proposals especially on related topics, such as: short interventions for substances of abuse; monitoring of psychotropic drug use in older patients; using analytical methods to understand risk factors for mental disorders; impacts of gaming in mental health; but also general themes, including: developing a research protocol; how to get an abstract accepted, to name a few.

User login

Subscribe to our ESCP mailing list

About ESCP

The European Society of Clinical Pharmacy (ESCP) is an organization that promotes, supports, implements and advances education, practice and research in clinical pharmacy in order to optimize outcomes for patients and society.

Get in touch

ESCP International Office
Theda Mansholtstraat 5B
2331JE Leiden
Netherlands

+31 715 766 157
Tu, We, Fr from 9 am - 4 pm